AC Immune (ACIU) Other Operating Expenses (2015 - 2026)

AC Immune (ACIU) has 12 years of Other Operating Expenses data on file, last reported at $14047.1 in Q1 2026.

• On a quarterly basis, Other Operating Expenses rose 1362.94% year-over-year to $14047.1 in Q1 2026; TTM through Mar 2026 was $139203.4, a 69.48% increase from a year earlier, with the FY2025 full-year figure at $113376.1, down 30.06% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $14047.1, down from $91335.4 in the prior quarter.
• Over the last five years, Other Operating Expenses for ACIU reached as high as $497009.0 in Q1 2022 and fell as low as -$1112.3 in Q1 2025.
• Historically, Other Operating Expenses has averaged $209386.3 across 5 years, with a median of $153131.0 in 2025.
• Across the five-year window, Other Operating Expenses plunged 101.43% in 2025 and jumped 1362.94% in 2026, its largest moves.
• Year by year, Other Operating Expenses stood at $414170.7 in 2022, then decreased by 3.37% to $400210.8 in 2023, then sank by 96.01% to $15981.3 in 2024, then jumped by 471.51% to $91335.4 in 2025, then plunged by 84.62% to $14047.1 in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $14047.1 in Q1 2026, $91335.4 in Q4 2025, and $33820.9 in Q2 2025.